Jagsonpal Pharmaceuticals News

Jagsonpal Pharma Board to Consider Buyback Proposal

Jagsonpal Pharmaceuticals has scheduled a board meeting for March 12, 2026, to consider and approve a buyback proposal for its fully paid-up equity shares of face value Rs. 2 each under applicable regulations.

Jagsonpal Pharmaceuticals Grants 11.53 Lakh ESOPs

Jagsonpal Pharmaceuticals' board committee approved grant of 11,52,500 employee stock options under ESOP 2022 at exercise price of Rs. 139.00 per option, vesting in 4 equal annual tranches.

Jagsonpal Pharma Grants 11.53L ESOPs at Rs 139

Jagsonpal Pharmaceuticals grants 11,52,500 employee stock options under ESOP 2022 at exercise price of Rs. 139.00 per option, vesting in 4 equal annual tranches starting from first anniversary.

Jagsonpal Pharma Outlines Growth Strategy for Next 2 Years

Jagsonpal Pharmaceutical expects 50% of growth from price increases and new products, with remaining from volume growth over the next one to two years during recent concall guidance.